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Disorder predispositions 
and protections of Labrador 
Retrievers in the UK
Camilla Pegram1*, Charlotte Woolley2, Dave C. Brodbelt1, David B. Church3 & Dan G. O’Neill1
The Labrador Retriever is one of the most popular dog breeds worldwide, therefore it is important to 
have reliable evidence on the general health issues of the breed. Using anonymised veterinary clinical 
data from the VetCompass Programme, this study aimed to explore the relative risk to common 
disorders in the Labrador Retriever. The clinical records of a random sample of dogs were reviewed 
to extract the most definitive diagnoses for all disorders recorded during 2016. A list of disorders was 
generated, including the 30 most common disorders in Labrador Retrievers and the 30 most common 
disorders in non-Labrador Retrievers. Multivariable logistic regression was used to report the odds 
of each of these disorders in 1462 (6.6%) Labrador Retrievers compared with 20,786 (93.4%) non-
Labrador Retrievers. At a specific-level of diagnostic precision, after accounting for confounding, 
Labrador Retrievers had significantly increased odds of 12/35 (34.3%) disorders compared to non-
Labrador Retrievers; osteoarthritis (OR 2.83) had the highest odds. Conversely, Labrador Retrievers 
had reduced odds of 7/35 (20.0%) disorders; patellar luxation (OR 0.18) had the lowest odds. This 
study provides useful information about breed-specific disorder predispositions and protections, 
which future research could evaluate further to produce definitive guidance for Labrador Retriever 
breeders and owners.
Abbreviations
CI  Confidence interval
EPR  Electronic patient record
IQR  Interquartile range
KC  The Kennel Club
OR  Odds ratio
UCD VGL  University of California Davis Veterinary Genetics Laboratory
Dogs have been domesticated for over 10,000 years, although the exact timeline and location of domestication 
is still  debated1–4. During domestication, selective breeding has progressively exaggerated various characteris-
tics and phenotypes of specific subsets of dogs to enhance their usefulness and desirability to humans and has 
ultimately led to the development of distinct breeds within the canine  species5. There are now over 350 recog-
nised dog breeds worldwide, which generally show reducing genetic diversity within each breed over  time6. The 
narrowing of gene pools through inbreeding has led to concerns about increasing susceptibility to inherited 
conditions and therefore reducing health overall in purebred dogs. However, the availability of reliable evidence 
on disorder predispositions and protections within many breeds is  limited7–9.
The Labrador Retriever is one of the most popular dog breeds worldwide and is lauded for its gentle and 
social nature, trainability and low  aggression10,11. It has been the most commonly registered Kennel Club (KC) 
breed in the UK for some decades; although briefly overtaken in 2018 by the French Bulldog, it soon regained 
first place in  201912. The breed originated from Newfoundland, Canada, where they were selected by fishermen 
to retrieve nets and pull carts. Following introduction into the UK in the mid-eighteenth century, the breed 
gained popularity for use as gundogs and was first recognised by the KC in  190313.
Labrador Retrievers have been regarded historically as a relatively healthy  breed14. Among the KC-regis-
tered subset of dogs in the UK, the median longevity of Labrador Retrievers was reported to be 12.3 years, 
approximately 1 year longer than the median across all KC-recognised breeds of 11.3  years15 However, in recent 
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years, reports on a growing number of inherited diseases have challenged this “healthy” image of the  breed16–26. 
Researchers at University of California Davis Veterinary Genetics Laboratory (UCD VGL) report that, while 
genetic diversity in Labrador Retrievers in the US is reasonable in comparison to other breeds, some bloodlines 
are more inbred than others, and they used this background to explain why Labrador Retrievers are predisposed 
to several  disorders14.
Using anonymised clinical data from primary-care veterinary practices in 2013, the most commonly reported 
disorders of Labrador Retrievers in the UK were otitis externa, obesity and  osteoarthritis27. Compared to pre-
vious reports that were based on the same data resource, that study suggested that Labrador Retrievers had 
increased prevalence of otitis externa, lipoma, gastroenteritis and skin laceration at a precise-level of diagnosis 
and enteropathic, aural, neoplastic and urinary disorders, traumatic injury and obesity at a grouped-level of 
diagnosis in comparison to Border Collies, Yorkshire Terriers, German Shepherd Dogs, Cocker Spaniels, Jack 
Russell Terriers, Staffordshire Bull Terriers and  crossbreeds28. Other studies have reported high prevalence of 
 obesity17,29,30,  osteoarthritis31 and  lipoma27,32,33 and high incidence of gastrointestinal  signs34 in Labrador Retriev-
ers. However, prevalence comparisons often fail to compare results against other breeds within the same study or 
to account for major confounding effects such as age, and therefore offer weak evidence of true relative disorder 
risk (predisposition or protection)8.
Disorder predisposition or protection within breeds can be inferred when there is a respective increased or 
decreased risk of a condition in a particular breed in comparison with some other relevant comparator group 
of  dogs8. Predispositions to 67 disorders are reported for Labrador  Retrievers8 and the breed also was found 
to be at a greater risk of diseases of the extremities relative to mixed breed  dogs35. A large survey of owners of 
pedigree dogs reported that Labrador Retrievers had a significantly higher prevalence of arthritis, osteoarthritis, 
elbow and hip dysplasia, lipoma, osteochondritis dissecans and skin cancer than 40 other KC-registered  breeds36. 
However, this study also reported that Labrador Retrievers had significantly lower prevalence (i.e. suggestion of 
protection) of 18 disorders, including anal gland blockages, blocked tear ducts, colitis, corneal ulcers and cryp-
torchidism. Other studies have reported decreased risk in Labrador Retrievers for benign prostatic  hyperplasia37, 
heart murmurs and degenerative mitral valve  disease38 and fatal acute  pancreatitis39. However, to date, studies 
have not reported predispositions and protections in Labrador Retrievers using one dataset, which would avoid 
compounding biases.
There is some evidence that targeted breeding strategies over recent decades have been associated with 
increased  longevity40 and decreased prevalence of hip and elbow  dysplasia41,42 in Labrador Retrievers. However, 
a deeper understanding of predispositions and protections among common disorders in Labrador Retrievers 
offers the potential to teach us as much about how to breed healthier dogs by breeding towards low disorder risk 
rather than just trying to breed away from high disorder risk as is the current preference in many dog breeding 
 strategies9,43. Using anonymised veterinary clinical data on dogs under primary veterinary care in the UK dur-
ing 2016 from the VetCompass  Programme44, this study aimed to compare the odds of diagnosis in Labrador 
Retrievers compared to non-Labrador Retrievers for each disorder in a combined list of the most common 
disorders in Labrador Retrievers and non-Labrador Retrievers, after accounting for major confounding demo-
graphic variables. Demographic data, such as breed, sex and neuter status, is routinely collected in primary-care 
databases, and therefore large quantities of data can be collected and used to robustly address the demographic 
risk factors for disorders. However, retrospective primary-care data are less optimal for gathering information 
on more nuanced risk factors, such as dog behaviour and owner lifestyle, including diet and exercise, and these 
were therefore not addressed in this  study45. This new evidence on predispositions and protections could sup-
port future research and contribute to better health guidance for Labrador Retriever breeders and owners. In 
addition, the findings could assist current Labrador Retriever owners to recognise common problems in their 
dogs, which may lead to earlier veterinary visits, quicker diagnosis and thus better prognosis.
Results
Demography. The study included a random sample of 22,333 dogs under veterinary care during 2016 in the 
UK from a population of 905,544. Breed information was missing for 85 (0.4%) dogs, which were excluded from 
further analysis, leaving 22,248 dogs (99.6%) in the analysis. There were 1462 (6.6%) Labrador Retrievers, which 
was the most common purebred breed. The most common breeds amongst non-Labrador Retrievers (20,786; 
93.4%) included 1304 (5.9% of the 22,248 dogs) Staffordshire Bull Terriers, 1168 (5.2%) Jack Russell Terriers, 
793 (3.6%) Shih-tzus, 771 (3.5%) Cocker Spaniels, along with 5981 (26.9%) crossbreeds. Data completeness for 
these 22,248 dogs were: breed 100.0%, age 98.9%, sex-neuter status 99.7%, insurance status 100.0% and adult 
bodyweight 66.9%.
Descriptive results were reported on 1462 Labrador Retrievers and 20,786 non-Labrador Retrievers (Table 1). 
The median age of Labrador Retrievers (5.23 years, IQR 2.13–8.97, range 0.17–17.7) was older than for non-
Labrador Retrievers (4.35 years, IQR 2.13–5.23, range 0.01–20.46) (p < 0.001). The median adult bodyweight of 
Labrador Retrievers (32.00 kg, IQR 28.50–36.17, range 19.60–46.75) was heavier than for non-Labrador Retriev-
ers (12.46 kg, IQR 7.88–22.60, range 1.41–85.00) (p < 0.001).
Total disorder count in Labrador Retrievers compared with non-Labrador Retrievers. Of 
the Labrador Retrievers, 996/1462 (68.1%) were recorded with ≥ 1 disorder during 2016 compared with 
13,667/20,786 (65.8%) of the non-Labrador Retrievers. After using multivariable methods to account for effects 
of age, sex-neuter status, at/above or below breed/sex mean bodyweight, insurance status and vet group, the odds 
of diagnosis with ≥ 1 disorder did not differ between Labrador Retrievers compared with non-Labrador Retriev-
ers (odds ratio [OR] 1.00; 95% confidence interval [CI] 0.89–1.13; p = 0.967).
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Specific-level predispositions and protections. The 30 most common specific-level disorders in Lab-
rador Retrievers and the 30 most common specific-level disorders in non-Labrador Retrievers resulted in a 
combined list of 35 specific-level disorders. The majority of these disorders overlapped, other than kennel cough, 
moist dermatitis, laceration, stiffness, coughing and papilloma which were exclusive to the 30 most common 
specific-level disorders in Labrador Retrievers. Conversely, heart murmur, flea infestation, atopic dermatitis, 
skin cyst, patellar luxation and retained deciduous tooth were exclusive to the 30 most common specific-level 
disorders in non-Labrador Retrievers.
After accounting for confounding using multivariable methods, Labrador Retrievers had significantly 
increased odds of 12/35 (34.3%) disorders compared to non-Labrador Retrievers. Disorders in Labrador Retriev-
ers with the highest odds (i.e. predisposition) were: osteoarthritis (OR 2.83; 95% CI 2.21–3.62; p < 0.001), lipoma 
(OR 2.45; 95% CI 1.79–3.34; p < 0.001), kennel cough (OR 2.27; 95% CI 1.54–3.36; p < 0.001), laceration (OR 2.16; 
95% CI 1.36–3.45; p = 0.001) and stiffness (OR 2.08; 95% CI 1.30–3.35; p = 0.002). Conversely, Labrador Retrievers 
had reduced odds (i.e. protection) for 7/35 (20.0%) specific-level disorders compared to non-Labrador Retriev-
ers. The specific-level disorders with greatest protection were: patellar luxation (OR 0.18; 95% CI 0.06–0.55; 
p = 0.003), heart murmur (OR 0.20; 95% CI 0.10–0.40 (p < 0.001), flea infestation (OR 0.22; 95% CI 0.11–0.47; 
p < 0.001), retained deciduous tooth (OR 0.28; 95% CI 0.10–0.75; p = 0.011) and periodontal disease (OR 0.43; 
95% CI 0.35–0.54; p < 0.001) (Fig. 1).
Grouped-level predispositions and protections. The 30 most common grouped-level disorders in 
Labrador Retrievers and the 30 most common grouped-level disorders in non-Labrador Retrievers resulted in 
a combined list of 32 grouped-level disorders. The majority of these disorders overlapped, other than collapsed 
and oral cavity disorder which were exclusive to the 30 most common grouped-level disorders in Labrador 
Retrievers. Conversely, hernia and disorder not diagnosed were exclusive to the 30 most common grouped-level 
disorders in non-Labrador Retrievers.
After accounting for confounding using multivariable methods, Labrador Retrievers had significantly 
increased odds of 8/32 (25%) disorders compared to non-Labrador Retrievers. The highest disorder predisposi-
tions were: oral cavity disorder (excluding dental) (OR 2.06; 95% CI 1.12–3.82; p = 0.021), neoplasia (OR 1.89; 
95% CI 1.55–2.29; p < 0.001), musculoskeletal disorder (OR 1.74; 95% CI 1.49–2.04; p < 0.001), ear disorder (OR 
1.55; 95% CI 1.31–1.83; p < 0.001) and complication associated with clinical care (OR 1.42; 95% CI 1.00–2.00; 
p = 0.047). Conversely, Labrador Retrievers had reduced odds of 8/32 (25%) grouped-level disorders compared 
to non-Labrador Retrievers. The grouped disorders with greatest protections were: hernia (OR 0.31; 95% CI 
0.13–0.75; p = 0.010), heart disease (OR 0.36; 95% CI 0.22–0.57; p < 0.001), dental disorder (OR 0.45; 95% CI 
0.37–0.55; p < 0.001), parasite infestation (OR 0.51; 95% CI 0.35–0.74; p < 0.001) and ophthalmological disorder 
(OR 0.56; 95% CI 0.43–0.72; p < 0.001) (Fig. 2). The Hosmer–Lemeshow test indicated no evidence of poor model 
fit (p > 0.05) in all multivariable models.
Table 1.  Descriptive statistics for demographic characteristics in Labrador Retrievers (n = 1462) and non-
Labrador Retrievers (n = 20,786) under primary veterinary care in the UK. The p value represents comparison 
of demographic variables between Labrador Retrievers and non-Labrador Retrievers. Missing data were not 
included unless it accounted for a significant proportion of the variable (> 10%).
Variable Category Labrador Retriever count (%) Non-Labrador Retriever count (%) p value
Age (years)
≤ 3 489 (33.7) 7636 (37.1)
 < 0.001
3 to < 6 325 (22.4) 5218 (25.4)
6 to < 9 275 (19.0) 3731 (18.2)
9 to < 12 206 (14.2) 2393 (11.6)
≥ 12 155 (10.7) 1586 (7.7)
Sex-neuter status
Male entire 455 (31.2) 6003 (29.0)
0.005
Male neutered 374 (25.7) 4854 (23.4)
Female entire 321 (22.0) 5328 (25.7)
Female neutered 308 (21.1) 4538 (21.9)
breed/sex mean bodyweight
At/above or below
At or above 491 (33.6) 6337 (30.5)
0.005Below 539 (36.9) 7507 (36.1)
Not recorded 432 (29.5) 6942 (33.4)
Insurance status
Insured 258 (17.6) 2718 (13.1)
0.001
Not insured 1204 (82.4) 18,068 (86.9)
Vet group
1 1 (0.1) 76 (0.4)
0.127
2 451 (30.8) 6848 (32.9)
3 74 (5.1) 929 (4.5)
4 253 (17.3) 3554 (17.1)
5 683 (46.7) 9379 (45.1)
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Discussion
This is the largest study to date that reports the comparative risk across a range of common disorders between 
Labrador Retrievers and all remaining dogs under primary veterinary care. The study characterised the demog-
raphy and health of a large cohort of 1462 Labrador Retrievers and 20,786 non-Labrador Retrievers under pri-
mary veterinary care in the UK. This current analytic study builds on a previous descriptive report of disorder 
prevalence in Labrador Retrievers under primary-veterinary  care27 by using a larger, more recent and more 
comprehensive dataset that includes dogs of all breeds and types under primary veterinary care to compare dis-
order risk between Labrador Retrievers and all other dog types (including purebreds and crossbreeds). This has 
enabled reporting of relative predispositions to, and protections from, common disorders, using methods that 
have previously been restricted due to the inability to access the large data resources required for such analyses.
To date, much of the emphasis when reporting on breed health has focused on identifying disorders with 
increased  risk8. However, reporting both disorder predispositions and protections offers a more balanced view of 
the overall health of the breed. The availability of large-scale data allows health comparison of individual breed 
against other groups across a range of disorders rather than just reporting risk for single disorders, which has 
been a limiting factor in many studies to  date28. Disorder predispositions may have been more readily identi-
fied and reported in common breeds, due to the availability of adequate counts of these dogs in the general 
population. However, it is important that we understand about disorder protections also since it is possible that 
we may learn as much about how to breed healthier dogs by breeding towards low disorder risk as by breeding 
away from high disorder risk as is the current preference in dog breeding  strategies9. In addition to information 
on predisposition and protections, we also need to consider absolute prevalence because even reduction from 
a high predisposition for a rare disorder may offer minimal overall health impact for a  breed46. For example, 
the top predisposition in Labrador Retrievers at a grouped-level of diagnostic precision was oral cavity disorder 
Figure 1.  Forest plot of the prevalence and multivariable logistic regression odds ratios with corresponding 
95% CIs (confidence intervals) for the combined list from the 30 most common disorders in Labrador Retrievers 
and the 30 most common disorders in non-Labrador Retrievers at a specific-level of diagnostic precision 
recorded in dogs under primary veterinary care at UK practices participating in the VetCompass Programme 
from January 1st 2016 to December 31st, 2016. Model variables accounted for included age, sex-neuter status, 
at/above or below breed/sex mean bodyweight, insurance status and vet group. Specific-level precision describes 
the original extracted terms at the maximal diagnostic precision recorded within the clinical notes.
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(excluding dental) (OR 2.06), however this was a relatively rare disorder overall with the prevalence in Labrador 
Retrievers 0.89% compared with 0.38% in non-Labrador Retrievers.
At a specific level of diagnostic precision, Labrador Retrievers had higher odds of 12/35 (34.3%) disorders 
compared to non-Labrador Retrievers and had reduced odds of 7/35 (20.0%) disorders. At a grouped-level of 
diagnostic precision, Labrador Retrievers had higher odds of 8/32 (25.0%) disorders and had reduced odds of 
8/32 (25.0%) disorders compared to non-Labrador Retrievers. A recent study with similar methodology based 
on Staffordshire Bull Terriers (SBTs), reported SBTs with higher odds of 4/36 (11.1%) specific-level disorders 
compared to non-SBTs and reduced odds of 5/36 (13.9%) disorders. At a grouped-level of diagnostic precision, 
SBTs had higher odds of 2/32 (6.3%) disorders and had reduced odds of 5/32 (15.6%) disorders compared to 
non-SBTs43. With significantly different risks between Labrador Retrievers and non-Labrador Retrievers for 
19/35 (54.3%) specific-level disorders, these results show that the disorder profile of Labrador Retrievers is 
quite different to dogs that are not of this breed. However, with substantial counts of both predispositions (12) 
and protections (7) among these discordant disorders, and without having taken account of additional factors 
relating to each disorder such as duration and  severity47, it is unclear whether the overall health of Labrador 
Retrievers can be concluded to be better or worse that non-Labrador Retrievers, but just different.
Musculoskeletal disorders. Labrador Retrievers showed predisposition to musculoskeletal disorders 
at a grouped-level of diagnostic precision (OR 1.74), in agreement with previous reports that the Labrador 
Retriever is predisposed to several musculoskeletal conditions including hip and elbow  dysplasia36,48–50, devel-
opmental orthopaedic  diseases51, immune-mediated  polyarthritis52,  osteoarthritis36,53 and cranial cruciate liga-
ment  rupture54. The prevalence of musculoskeletal disorders reported in Labrador Retrievers in the current 
study (14.91%) lies between previously reported estimates from studies with similar designs based on Labrador 
Retrievers under primary-veterinary care (12.6–16.2%)27,28 and is similar to the prevalence of ‘extremity-related’ 
diseases reported in clinical data from Labrador Retrievers in the Netherlands (15.6%)35. At a specific-level 
of diagnostic precision, Labrador Retrievers had higher odds of osteoarthritis (OR 2.83) compared to non-
Figure 2.  Forest plot of the prevalence and multivariable logistic regression odds ratios with corresponding 
95% CIs (confidence intervals) for the combined list from the 30 most common disorders in Labrador 
Retrievers and the 30 most common disorders in non-Labrador Retrievers at a grouped-level of diagnostic 
precision recorded in dogs under primary veterinary care at UK practices participating in the VetCompass 
Programme from January 1st 2016 to December 31st, 2016. Model variables accounted for included age, sex-
neuter status, at/above or below breed/sex mean bodyweight, insurance status and vet group. Grouped-level 
precision describes the original extracted terms mapped to a general level of diagnostic precision.
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Labrador Retrievers, slightly higher than a previous report using primary-veterinary care data (OR 2.47)31 and 
the highest overall predisposition identified in the current study. Labradors Retrievers also had increased odds of 
lameness (OR 1.62) and stiffness (OR 2.08), which are clinical signs commonly associated with musculoskeletal 
 disorders55. However, clinical signs such as ‘lameness’ and ‘stiffness’ are not diagnostic and might be associated 
with a range of diagnoses, including  osteoarthritis56. Therefore, the absolute risk of osteoarthritis in Labrador 
Retrievers may be higher than we report, which is concerning considering the reported negative impact of 
musculoskeletal disorders on canine welfare and  lifespan57. The British Veterinary Association and KC’s hip 
and elbow dysplasia screening schemes have been running for over 50 years and over 20 years respectively, with 
the purpose of improving breeding programs to reduce the severity of breed predispositions to musculoskeletal 
 disorders58. According to the current study, Labrador Retrievers are still at increased risk, which highlights that 
a review of the schemes and more stringent prevention methods may be appropriate and timely. However, the 
current study did not quantify any change in risk. It is estimated that approximately 30% of dogs are Kennel 
Club  registered59, therefore it might be that the proportion of affected dogs differ between the Kennel Club and 
non-Kennel Club registered populations.
Despite the predisposition to overall musculoskeletal conditions reported in the current study, Labrador 
retrievers showed protection to patellar luxation at a specific-level of diagnostic precision (OR 0.18). This is in 
agreement with a previous study of KC-registered breeds which reported a significantly lower prevalence of patel-
lar laxation in Labrador Retrievers compared to other  breeds36. These recent studies contrast to earlier reports 
that suggested an overrepresentation of Labrador Retrievers diagnosed with patellar  luxation60–63. Lateral patellar 
luxation has been observed more often in larger breed  dogs61, however these earlier studies included relatively 
small numbers of dogs and used univariable analyses which might have led to confounding of the  results64. As a 
breed exhibiting protection, Labrador Retrievers could be used as a model to explore conformational and other 
factors that may assist to develop strategies to reduce the prevalence in other higher-risk breeds.
Obesity. Labrador Retrievers showed predisposition to obesity in the current study (OR 1.62), which is simi-
lar to odds ratios previously reported (OR 1.47–1.70)29,45,65. The welfare of dogs is compromised when they are 
overweight or obese, with obesity associated with a number of disorders including osteoarthritis, type II diabetes 
mellitus, lung problems and urinary and reproductive  disorders47,66. The quality of life of affected dogs has been 
reported as improved after successful weight  loss67,68. Amongst others previously stated, obesity has been co-
morbidly associated with musculoskeletal disorders in  dogs29. Predisposition to both musculoskeletal disorders 
and obesity in the Labrador Retriever suggests the probability of a causal link between obesity and musculoskel-
etal disorders, which gives further impetus to current moves to raise the status of obesity to be formally classified 
as a veterinary disease and to be prioritised within breeding and clinical  programmes69. In consequence, it is 
important that practical preventative advice is given to owners about the susceptibility of Labrador Retrievers to 
obesity and associated musculoskeletal disorders to improve the welfare of the breed. It should be noted that evi-
dence for obesity required information recorded within the EPR indicating that the dog was obese at any point 
during 2016. Given that bodyweight was missing for 29.5% of Labrador Retrievers and 33.4% non-Labrador 
Retrievers, it is possible that some of these dogs were obese but not recorded as such in the clinical notes. It is 
difficult to ascertain how this might vary by breed, but this finding could be used to focus efforts in encouraging 
veterinary professionals to routinely record bodyweight of all dogs. The focus of the current study was to report 
disorder predispositions and protections in Labrador Retrievers. However, given the predisposition identified 
and welfare impact, obesity and its comorbid conditions is an important area for future research.
Neoplasia. Labrador Retrievers showed predisposition to neoplasia (OR 1.89) and mass disorders (OR 1.31) 
at a grouped-level of diagnostic precision, with estimated prevalences of 9.71% and 7.66% respectively. These 
values are similar to the respective estimates reported previously by studies of Labrador Retrievers with similar 
methodologies of 7.4–14.8% for neoplasia and 4.80–8.26% for mass  disorders27,28. These results are supported 
by reported predispositions in Labrador Retrievers to neoplasms including lingual squamous cell  carcinoma70, 
mast cell  tumours71–73, soft tissue  sarcoma72  melanomas74 and various neoplasms of the thoracic  limb75.
Labrador Retrievers showed predisposition to lipoma (OR 2.45) at a specific-level of diagnostic precision in 
the current study. This odds ratio is comparable to that reported in a recent study, where Labrador Retrievers 
had the  3rd highest odds of lipoma compared to crossbreeds (OR 2.19), behind the Dobermann Pinscher and 
 Weimaraner33. These findings also support earlier research which identified breed predisposition to lipoma in 
Labrador  Retrievers32. Whilst lipomas are often clinically  unremarkable33, they ranked 4th among the top 8 
disorders based on VetCompass Welfare Impact score, with a median annual duration of over 50% in affected 
 dogs47. Therefore, considering the predisposition identified, high absolute prevalence value disorder duration, 
breed health reforms to reduce the prevalence of lipomas should be considered as worthwhile priorities. Labrador 
Retrievers showed predisposition to papilloma (OR 1.74) in the current study, which has not been previously 
reported from primary-care data. Prior studies based on primary-care data have reported prevalence of skin 
masses in Labrador Retrievers as 3.2% and 2.5%  respectively27,28, although it is not possible to discern what 
proportion of these were papilloma. It should be noted that the number of Labrador Retrievers with papilloma 
in the current study was relatively small (n = 19), therefore this predisposition should be interpreted in line with 
low prevalence as being of lower priority for the breed. However, a recent study has highlighted the oncogenic 
potential of papillomas, with benign papillomas transforming in to malignant  carcinomas76. Veterinarians should 
be aware of this oncogenic potential and discuss with owners of affected dogs.
Respiratory disorders. Previous studies based on primary-care data have not reported the prevalence of 
kennel cough, but Labrador Retrievers were identified as predisposed (OR 2.27) in the current study, in contrast 
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to a KC-registered breed based study which did not identify Labrador Retrievers with significantly higher or 
lower within breed prevalence of kennel cough compared to the prevalence across breeds  overall36. Increased 
odds of coughing or upper respiratory tract disorders in Labrador Retrievers were not identified in the current 
study and the prevalence of these two conditions reported was similar to those reported previously by studies 
with similar  methodologies27,28. Coughing is a pathognomonic presenting sign of the kennel cough syndrome 
that can involve a spectrum of infectious agents including viral, bacterial and Mycoplasma77. It would be useful 
to know which (if any) particular pathogens Labrador Retrievers are susceptible to that cause kennel cough, and 
if environmental factors such as increased contact with other dogs has an impact on their susceptibility. Labra-
dor Retrievers are a sociable breed and may be kept as family companions, service dogs, guide dogs or working 
 gundogs13. Transmission of pathogens associated with kennel cough is both by direct contact and indirectly by 
aerosolized droplets from coughing or sneezing dogs and by  fomites78. Therefore, if Labrador Retrievers spend 
an increased amount of time in contact with other dogs and humans compared with different breeds, the risk of 
kennel cough transmission might be higher. Further research is required to elucidate these relationships.
Dental disorders. Labrador Retrievers showed protection to dental disorders at a grouped-level of diagnos-
tic precision (OR 0.45) and protection to periodontal disease at a specific-level of diagnostic precision (OR 0.43), 
with estimated prevalences of 8.14% and 7.11%, respectively. These values are higher than the respective esti-
mates reported previously by studies with similar methodologies of 3.8–5.5% for dental disorders and 3.2–4.3% 
for periodontal  disease27,28. Our prevalence estimate for periodontal disease is considerably lower than previous 
estimates based on prospective planned dental examinations in Labrador Retrievers (56.6%)79 and estimates in 
dogs generally (60.0–86.3%)80,81, suggesting the prevalence of periodontal disease is underreported in primary-
care data, although different study populations may in part account for this difference. The current study also 
reported that Labrador Retrievers had protection (OR 0.28) to retained deciduous teeth, which is in agree-
ment with previous research in which Labrador Retrievers did not develop as many cases of unerupted teeth as 
 Boxers82. Although Labrador Retrievers had protection to dental disorders in the current study, they still have a 
relatively high prevalence of such conditions. Exploration of the reasons why Labrador Retrievers are protected 
in comparison to other breeds may enable these protective factors to be increased so that the breed prevalence 
decreases further, and that the health and welfare of other breeds might also be improved.
Cardiovascular disorders. Labrador Retrievers showed protection to heart disease at a grouped-level of 
diagnostic precision (OR 0.36) and had protection to heart murmur at a specific-level of diagnostic precision 
(OR 0.20), with estimated prevalence of 1.30% and 0.55% respectively, which are lower than respective estimates 
reported previously by O’Neill et al. (2014) of 1.5% in both  cases28. The results of the current study agree with 
research that reported Labrador Retrievers have reduced odds of degenerative mitral valve disease and heart 
murmur in comparison with other  breeds38. Based on a survey of owners, Wiles et al.36 reported that Labra-
dor Retrievers had significantly lower prevalence of mitral valve disease, heart murmur and irregular heartbeat 
in comparison with other KC-registered breeds. Conversely, Labrador Retrievers have been reported to have 
predispositions to supraventricular  tachycardia83, atrioventricular  block84, pericardial  effusion85 and congenital 
heart  disease86. However, these specific diagnoses are less common and were not identified in the current study 
population in sufficient numbers to be included in the analysis. It might be that the historical selection of Lab-
rador Retrievers as a working  gundog13 has inadvertently resulted in selection against cardiac disease over many 
decades. Therefore, there may be value in using Labrador Retrievers in cross breeding programmes to outcross 
other breeds affected with specific cardiac  predispositions7.
Parasitic disorders. Labrador Retrievers showed protection to parasitic disorders at a grouped-level of 
diagnostic precision (OR 0.51) and flea infestation at a specific-level of diagnostic precision (OR 0.22), with 
estimated prevalence of 2.05% and 0.48%, respectively. Results for flea infestation in Labrador Retrievers has not 
been previously reported in primary-care studies, but our estimated prevalence for parasite infestation overall is 
between estimates reported previously by VetCompass studies with similar methodologies (1.7–3.5%)27,28. The 
prevalence of flea infestation in our results was considerably lower than reported in veterinary-based surveys of 
UK dogs (6.82–14.40%)87,88. The higher prevalence reported by Abdullah et al. might be because their method-
ology required veterinarians to adhere to a strict protocol when collecting samples, but the authors suggested 
that the true prevalence might be higher still, due to the poor sensitivity of qPCR methods. Additionally, Bond 
et al. found that almost half of dog owners did not know that their dogs had flea infestations, which could lead 
to considerable underestimation of the true prevalence via veterinary  reporting87. Furthermore, it is likely that 
many owners buy anti-parasitic treatments over the counter, so it is not clear how accurately veterinary clinical 
data represents the true prevalence of parasite infestation. It is unclear why Labrador Retrievers have protection 
to parasite infection, but it could be due to their characteristically short coat-type, which has been associated 
with reduced likelihood of tick  infestation89 and flea  infestation90 in dogs, perhaps due to easier removal of the 
parasite during grooming (by the dog or owner) or due to the increased difficulty for the parasite to attach and 
grip to the coat. Labrador Retrievers’ affinity to water might also help to remove external parasites, especially 
if they are often bathed or allowed to swim outdoors. However, we did not separate out different confounding 
factors in the current study, therefore future studies that explore demographic, environmental, management and 
ownership factors as separate entities may help to further evaluate this finding.
Limitations. The limitations of this study are similar to those in previous VetCompass publications with 
similar methodologies, largely based on the nature of retrospective analysis of electronic patient record  data28,91. 
Many disorders reported in the current study have environmental risk factors and some of these may be breed-
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specific, however it is not possible to assess these with primary-care data alone. Further prospective studies 
might evaluate the influence of non-genetic factors, such as owner and dog behaviours and lifestyle, including 
diet and exercise, on the development of disorders identified in the current study. The severity and duration 
of disorders are not reported here, which could provide further insights into the nature and ranking of breed 
 predispositions47. Comparing the relative number of predispositions to protections does not necessarily reflect 
breed health without a measure of severity, however the study findings highlight the types of conditions Labra-
dor Retrievers are predisposed to and protected from.
We classified dogs as either ‘Labrador Retriever’ or ‘non-Labrador Retriever’ and removed any dogs with 
their breed information missing. The high percentage (28.8%) of crossbreeds in our non-Labrador Retrievers 
might have caused some dilution of the phenotype. For example, Labradoodles are a crossbreed of Labrador 
Retriever and Poodle and although not recognised by the KC, are an increasingly popular breed in the  UK92. 
It is difficult to ascertain from the data what proportion of the non-Labrador Retrievers had partial Labrador 
Retriever progeny and to what extent these dogs affected the results. However, inclusion of crossbreeds with 
partial Labrador Retriever progeny would result in an underestimation of the breed effects, rather than overesti-
mation. Therefore, we can be more confident that a true association exists for the results identified as statistically 
significant in this study.
A random subset of all dogs were included in this study due to temporal constraints on data coding, which 
might have caused some of the less common disorders to be underpowered and resulted in artificially inflated 
or deflated odds ratios. Therefore, the count, prevalence, odds ratios and confidence intervals should be consid-
ered together when interpreting the results. As discussed previously, presenting signs where more than one was 
listed were reported as the first given, which might have affected the data due to linguistic biases. Novel methods 
of diagnosis coding based on natural language processing recently developed by VetCompass might provide a 
solution to these problems in the  future93.
We treated missing values as a separate category within the analysis. Using this approach may allow for 
residual confounding if the missing category is not  homogenous94, but provides a less biased estimate than 
excluding this  data95. We use multiple comparisons in this study and adherence to a cut-off p value of less than 
0.05 to infer significance can lead to a Type 1 error of accepting false positive results. Furthermore, the small 
number of cases in some disorders that we report might have led to a type 2 error of accepting false negative 
results. We recommend that readers do not rely on the p values of odds ratios but consider the confidence levels, 
prevalence percentages and other results to interpret our  findings96. The results for each of the disorders assessed 
should be interpreted as exploratory rather than confirmatory.
Conclusion
This study evaluated a range of disorders and should be considered exploratory rather than confirmatory. The 
individual results should be confirmed in future a priori studies to increase confidence in the findings. With 
significantly different risks between Labrador Retrievers and non-Labrador Retrievers for 19/35 (54.3%) specific-
level disorders, these results show that the disorder profile of Labrador Retrievers is  quite different to dogs that 
are not of this breed. Labrador Retrievers show predisposition to some common disorders including osteoarthritis 
and lipoma but show protection to some common disorders including patellar luxation and heart murmur. The 
findings can alert current Labrador Retriever owners about key issues to monitor in their dogs, which may lead 
to earlier veterinary visits, quicker diagnosis and thus better prognosis. Further work should aim to elucidate 
the reasons for the predispositions and protections to disorders in order to benefit not only Labrador Retrievers 
but the wider canine community.
Methods
The study population included all available dogs under primary veterinary care at clinics participating in the 
VetCompass Programme during 2016. Dogs under veterinary care were defined as those with either (a) at least 
one electronic patient record (EPR) (VeNom diagnosis term, free-text clinical note, treatment or bodyweight) 
recorded during 2016 or (b) at least one EPR recorded during both 2015 and 2017. Including dogs that had 
received care at the clinic in 2015 and 2017 broadened the inclusivity of the dogs in the study by including dogs 
that were under the care of the practice in 2016, but who did not receive any direct treatment in this period. 
Therefore, this study population should be more representative of the wider dog population. VetCompass collates 
de-identified EPR data from primary-care veterinary practices in the UK for epidemiological  research44. Data 
fields available to VetCompass researchers include a unique animal identifier along with species, breed, date of 
birth, sex, neuter status, insurance status, and bodyweight, and also clinical information from free-form text 
clinical notes, summary diagnosis  terms97 and treatment with relevant dates.
A cohort study design was used to estimate the 1-year (2016) period prevalence of the most commonly 
diagnosed disorders in Labrador Retrievers and for all other  dogs98. Sample size calculations in Epi info (CDC)99 
estimated that, based on a UK dog population of 10  million100, approximately 834 Labrador Retrievers and 16,673 
non-Labrador Retrievers would be needed to detect an odds ratio of ≥ 2.0 based on an estimated 2.5% of Labrador 
Retrievers having a specific disorder during the study period, assuming 80% power and 95% confidence with a 
20:1 ratio of non-Labrador Retrievers to Labrador  Retrievers43,99. Ethics approval was obtained from the RVC 
Ethics and Welfare Committee (reference number SR2018-1652).
Breed information entered by the participating practices was cleaned and mapped to a VetCompass breed list 
derived and extended from the VeNom Coding breed  list97. Dogs that were recorded as Labrador Retriever were 
categorised as Labrador Retriever and dogs recorded with any other breed or crossbreed term were categorised as 
non-Labrador Retriever. Neuter status was defined by the final available EPR neuter value and was combined with 
sex to create four categories: female entire, female neutered, male entire and male neutered. Adult bodyweight 
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for an individual dog was defined as the mean of all bodyweight (kg) values recorded for the dog after reaching 
18 months old. Mean adult bodyweight was reported overall and broken down by sex for all breeds with adult 
bodyweight available for at least 100 dogs. Based on previous  reports43,101, bodyweight was further categorized 
as “at or above the breed/sex mean”, “below the breed/sex mean” and “no recorded bodyweight”. Age was defined 
as the age (years) at December 31, 2016 and was categorised into five groups: ≤ 3.0, 3.0 to < 6.0, 6.0 to < 9.0, 9.0 
to < 12.0 and ≥ 12.0. Each veterinary clinic was categorised into one of the five practice groups included in the 
study. The practice groups included in the current study were distributed throughout the UK and were assigned 
a code during analysis to ensure anonymity. Vet group was included as a fixed effect to adjust for clustering at 
the clinic level. Insurance status was categorised as insured or not insured as recorded by the final available EPR. 
Missing data were recorded as “Not recorded” and, in line with previous reports based on EPR data, included in 
the analysis if this category accounted for > 10% of the study  variable102. A systematic review on the approaches 
to handling missing data reported that complete-case analysis may seriously bias study  results95, therefore we 
chose to include missing data as a separate category in the analysis if it accounted for a significant proportion 
(> 10%) of the study variable to minimize bias. This approach allows dogs with missing data for one variable to 
still contribute to the overall analyses based on information that is complete for other variables.
The VetCompass database allows for random ordering of unique animal identification numbers from the 
overall population. This facilitated random selection of the clinical records of a sample of dogs of all types. The 
clinical records were reviewed in detail to extract the most definitive (i.e. specific) diagnoses recorded for all 
disorders that existed during  201628. Elective (e.g. neutering) or prophylactic (e.g. vaccination) clinical events 
were not included as disorders. No distinction was made between pre-existing and incident disorder presenta-
tions. Disorders described within the clinical notes using presenting sign terms (e.g. ‘vomiting’ or ’vomiting and 
diarrhoea’), but without a formally recorded clinical diagnostic term, were included using the first sign listed (e.g. 
vomiting). Obesity in dogs is a disorder that might be described in EPRs using different  synonyms103. In line with 
previous publications based on primary care data, evidence for obesity required information recorded within 
the EPR indicating that the dog showed evidence of overweight to any degree during  201645,103. The extracted 
diagnosis terms were mapped to a dual hierarchy of diagnostic precision for analysis: specific-level precision and 
grouped-level precision as previously  described28. Briefly, specific-level precision terms described the original 
extracted terms at the maximal diagnostic precision recorded within the clinical notes (e.g. inflammatory bowel 
disease would remain as inflammatory bowel disease). The researchers made no attempts to second-guess underly-
ing disorders in cases with presenting signs (e.g. lameness) recorded in lieu of formal diagnoses. Grouped-level 
precision terms mapped the original diagnosis terms to a general level of diagnostic precision (e.g. inflammatory 
bowel disease would map to gastro-intestinal).
Following data checking for internal validity and cleaning in Excel (Microsoft Office Excel 2013, Microsoft 
Corp.), analyses were conducted using SPSS version 24.0 (IBM Corp). The sex-neuter status, age, mean adult 
bodyweight, at/above or below breed/sex mean bodyweight and insurance status for Labrador Retrievers and 
non-Labrador Retrievers under veterinary care during 2016 were described.
One-year period prevalence values were reported separately for Labrador Retrievers and non-Labrador 
Retrievers. One-year period prevalence described the proportion of dogs from the study population recorded 
as having a given condition during 2016. A combined list of disorders was generated that included the 30 most 
common disorders in Labrador Retrievers and the 30 most common disorders in non-Labrador Retrievers so 
that equal weighting was given to the common disorders in both groups. Multivariable modelling using binary 
logistic regression was used to report the odds of each of these disorders in Labrador Retrievers compared with 
non-Labrador Retrievers. Predisposition was defined as higher breed odds for a disorder after accounting for 
other demographic factors. Conversely, protection was defined as lower breed odds for a disorder after account-
ing for other demographic factors. A predisposition or protection was considered significant at the 5% level i.e. 
p < 0.05. For each specific-level and grouped disorder, a separate multivariable model was created that included 
a consistent list of variables based on information  theory104,105. Breed was the a priori factor of interest and the 
models additionally included age (years), sex-neuter status, at/above or below breed/sex mean bodyweight, insur-
ance status and vet group as potential confounders. Individual bodyweight serves as a proxy of breed, therefore 
we included “at/above or below breed/sex mean bodyweight” to account for within breed variation. Relaxation 
on financial constraints to presentation for veterinary care, diagnostic procedures and surgical management 
through insurance has been shown to increase diagnostic probability in many  conditions33, therefore insurance 
was considered as a confounding variable in the current study.
Normality of continuous variables (i.e. age and bodyweight) was assessed graphically and using the Kolmogo-
rov–Smirnov (K–S) test for  normality106, with continuous variables ummarised using median, interquartile range 
(IQR) and range. Mann–Whitney, Chi-square or Fisher’s exact tests were used as appropriate for comparison 
of demographic data between cases and non-cases107,108. Model fit was assessed with the Hosmer–Lemeshow 
 Test109. Statistical significance was set at the 5% level. All figures were created in R statistical software (R version 
3.6.1) using the “forestplot”  package110.
Ethics approval. Ethics approval was granted by the RVC Ethics and Welfare Committee (reference number 
URN Ref SR2018-1652).
Data availability
The datasets generated during and/or analysed during the current study will be made available at the RVC 
Research Online repository: https:// resea rchon line. rvc. ac. uk/ id/ eprint/ 12650/.
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